Cornerstone Capital Management Holdings’s Puma Biotechnology PBYI Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.11M	Sell	11,207 -900	-7%	-$101K	0.01%	878
2017 Q3	$1.45M	Sell	12,107 -1,000	-8%	-$93K	0.01%	851
2017 Q2	$1.14M	Sell	13,107 -3,133	-19%	-$175K	0.01%	871
2017 Q1	$603K	Buy	+16,240	New	+$593K	﹤0.01%	1024
2016 Q4	–	Sell	-3,700	Closed	-$247K	–	1399
2016 Q3	$247K	Buy	+3,700	New	+$187K	﹤0.01%	1169
2015 Q2	–	Sell	-3,500	Closed	-$826K	–	1465
2015 Q1	$826K	Hold	3,500	–	–	0.01%	922
2014 Q4	$662K	Sell	3,500 -100	-3%	-$22.2K	0.01%	943
2014 Q3	$859K	Buy	+3,600	New	+$739K	0.01%	900

Other funds holding PBYI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cornerstone Capital Management Holdings's PBYI Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Puma Biotechnology (PBYI) stake by 7.4% in Q4 2017, selling an estimated $101K and leaving 11,207 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #878.

Cornerstone Capital Management Holdings first reported a position in PBYI in Q3 2014 and has held it in 8 quarters since. The position peaked at $1.45M in Q3 2017. 203 funds tracked by Wall St. Rank hold PBYI as of Q4 2017.

Cornerstone Capital Management Holdings held 11,207 shares of Puma Biotechnology worth $1.11M as of Q4 2017.
Cornerstone Capital Management Holdings sold 900 Puma Biotechnology shares in Q4 2017, an estimated $101K.
Puma Biotechnology made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #878 holding.
Cornerstone Capital Management Holdings first reported a position in Puma Biotechnology in Q3 2014 and has held it in 8 quarters since.
Cornerstone Capital Management Holdings's Puma Biotechnology position peaked at $1.45M in Q3 2017.
203 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.